Treating Foot Drop in People With Multiple Sclerosis Using Electrical Stimulation
Functional Electrical Stimulation to Treat Foot Drop in People With Multiple Sclerosis
1 other identifier
interventional
10
1 country
1
Brief Summary
People with multiple sclerosis (MS) often suffer from foot drop, which impairs their walking ability. Foot drop is the inability to lift the foot during the swing phase of walking. The purpose of this study is to find out if electrical stimulation of the leg, using the Bioness L300 Foot Drop System, can be used to treat foot drop in people with MS. It is expected that using this system will reduce foot drop, and therefore improve walking ability, particularly in the areas of speed, strength, balance and falls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Jun 2014
Typical duration for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2014
CompletedFirst Posted
Study publicly available on registry
April 25, 2014
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedSeptember 7, 2016
September 1, 2016
2.1 years
April 23, 2014
September 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Speed during the 10-metre straight line walking test
During the 10-metre straight line walking test, participants walk 10 metres, as marked on the floor with tape, at a steady, self-selected pace, with room for acceleration and deceleration before and after the test. The test measures walking speed, which assesses overall gait function and stability. Participants will complete this test both with and without using the L300 device.
12 weeks
Secondary Outcomes (10)
Distance travelled during the 4-minute figure-8 walking test
12 weeks
Speed during the 10-metre straight line walking test
4 weeks
Speed during the 10-metre straight line walking test
8 weeks
Distance travelled during the 4-minute figure-8 walking test
4 weeks
Distance travelled during the 4-minute figure-8 walking test
8 weeks
- +5 more secondary outcomes
Study Arms (1)
Bioness L300 Foot Drop System
EXPERIMENTALParticipants will use the Bioness L300 Foot Drop System for walking daily during the 12 weeks of the study.
Interventions
Participants will use the Bioness L300 Foot Drop System during waking hours for 12 weeks.
Eligibility Criteria
You may qualify if:
- Have multiple sclerosis for at least one year
- Being 18 years of age or older
- Have upper motor neuron-type foot drop (based on the study clinician's medical opinion)
- Able to ambulate at least 10 metres independently or with one person assistance, with or without walking aid
- Having the cognitive capacity to understand and follow the study protocol
You may not qualify if:
- Severe cardio-respiratory difficulties (including using a pace-maker) or other health issues that may prohibit walking training
- Significant lower motor neuron neuropathy (based on the study clinician's medical opinion)
- History of frequent falls (more than once a week)
- Having used functional electrical stimulation to treat gait within the past six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- Riverview Health Centre Foundationcollaborator
Study Sites (1)
Rehabilitation Hospital, Health Sciences Centre
Winnipeg, Manitoba, R3A 1M4, Canada
Related Publications (4)
Laufer Y, Hausdorff JM, Ring H. Effects of a foot drop neuroprosthesis on functional abilities, social participation, and gait velocity. Am J Phys Med Rehabil. 2009 Jan;88(1):14-20. doi: 10.1097/PHM.0b013e3181911246.
PMID: 19096288BACKGROUNDRing H, Treger I, Gruendlinger L, Hausdorff JM. Neuroprosthesis for footdrop compared with an ankle-foot orthosis: effects on postural control during walking. J Stroke Cerebrovasc Dis. 2009 Jan;18(1):41-7. doi: 10.1016/j.jstrokecerebrovasdis.2008.08.006.
PMID: 19110144BACKGROUNDStein RB, Everaert DG, Thompson AK, Chong SL, Whittaker M, Robertson J, Kuether G. Long-term therapeutic and orthotic effects of a foot drop stimulator on walking performance in progressive and nonprogressive neurological disorders. Neurorehabil Neural Repair. 2010 Feb;24(2):152-67. doi: 10.1177/1545968309347681. Epub 2009 Oct 21.
PMID: 19846759BACKGROUNDO'Dell MW, Dunning K, Kluding P, Wu SS, Feld J, Ginosian J, McBride K. Response and prediction of improvement in gait speed from functional electrical stimulation in persons with poststroke drop foot. PM R. 2014 Jul;6(7):587-601; quiz 601. doi: 10.1016/j.pmrj.2014.01.001. Epub 2014 Jan 9.
PMID: 24412265BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen D Ethans, MD
Health Sciences Centre, Winnipeg
- STUDY DIRECTOR
Jessie R Shea, MSc
Health Sciences Centre, Winnipeg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Spinal Cord Rehabilitation Program
Study Record Dates
First Submitted
April 23, 2014
First Posted
April 25, 2014
Study Start
June 1, 2014
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
September 7, 2016
Record last verified: 2016-09